1. Home
  2. CVAC vs EDN Comparison

CVAC vs EDN Comparison

Compare CVAC & EDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • EDN
  • Stock Information
  • Founded
  • CVAC 2000
  • EDN 1992
  • Country
  • CVAC Germany
  • EDN Argentina
  • Employees
  • CVAC N/A
  • EDN N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • EDN Electric Utilities: Central
  • Sector
  • CVAC Health Care
  • EDN Utilities
  • Exchange
  • CVAC Nasdaq
  • EDN Nasdaq
  • Market Cap
  • CVAC 1.2B
  • EDN 1.1B
  • IPO Year
  • CVAC 2020
  • EDN 2007
  • Fundamental
  • Price
  • CVAC $5.35
  • EDN $17.07
  • Analyst Decision
  • CVAC Hold
  • EDN
  • Analyst Count
  • CVAC 3
  • EDN 0
  • Target Price
  • CVAC $6.83
  • EDN N/A
  • AVG Volume (30 Days)
  • CVAC 471.1K
  • EDN 169.3K
  • Earning Date
  • CVAC 11-11-2025
  • EDN 08-11-2025
  • Dividend Yield
  • CVAC N/A
  • EDN N/A
  • EPS Growth
  • CVAC N/A
  • EDN N/A
  • EPS
  • CVAC 1.01
  • EDN 0.21
  • Revenue
  • CVAC $599,540,810.00
  • EDN $1,911,272,136.00
  • Revenue This Year
  • CVAC N/A
  • EDN $37.74
  • Revenue Next Year
  • CVAC $23.95
  • EDN $27.07
  • P/E Ratio
  • CVAC $5.32
  • EDN $4.09
  • Revenue Growth
  • CVAC 675.15
  • EDN 23.18
  • 52 Week Low
  • CVAC $2.37
  • EDN $16.43
  • 52 Week High
  • CVAC $5.72
  • EDN $51.69
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 44.43
  • EDN 45.93
  • Support Level
  • CVAC $5.32
  • EDN N/A
  • Resistance Level
  • CVAC $5.41
  • EDN $19.38
  • Average True Range (ATR)
  • CVAC 0.04
  • EDN 1.25
  • MACD
  • CVAC -0.01
  • EDN -0.90
  • Stochastic Oscillator
  • CVAC 33.33
  • EDN 74.54

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About EDN Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor)

Empresa Distribuidora y Comercializadora Norte SA is engaged in the distribution and sale of electricity. The firm's concession area covers the northern portion of the city of Buenos Aires mainly to residential, commercial, industrial, and public service.

Share on Social Networks: